TY - JOUR
KW - anticoagulation
KW - myocardial ischemia
KW - peripheral vascular diseases
KW - Rivaroxaban
KW - utilisation
AU - N. Hunt
AU - R. Pajouheshnia
AU - A. Salih
AU - S. van Doorn
AU - P. Souverein
AU - M. Bazelier
AU - O. Klungel
AU - H. Gardarsdottir
AD - Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.
Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Deparment of General Practice, Julius Center for Health Sciences and Primary care, University Medical Centre Utrecht, Utrecht, The Netherlands.
Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands.
Department of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
AN - 36890111
BT - Br J Clin Pharmacol
DO - 10.1111/bcp.15708
DP - NLM
ET - 2023/03/09
LA - eng
N1 - 1365-2125
Hunt, Nicholas B
Orcid: 0000-0003-1677-6025
Pajouheshnia, Romin
Salih, Allan
van Doorn, Sander
Souverein, Patrick C
Orcid: 0000-0002-7452-0477
Bazelier, Marloes T
Klungel, Olaf H
Gardarsdottir, Helga
Orcid: 0000-0001-5623-9684
Journal Article
England
Br J Clin Pharmacol. 2023 Mar 8. doi: 10.1111/bcp.15708.
PY - 2023
SN - 0306-5251
T2 - Br J Clin Pharmacol
TI - Prescribing of Low-dose Rivaroxaban in Patients with Atherosclerotic Cardiovascular Disease in the United Kingdom and the Netherlands
ER -